News 2/24/23
Top News
Teladoc Health reports Q4 results: revenue up 15%, EPS –$0.23 versus –$0.07, beating revenue expectations but falling short on earnings.
The company reported a staggering $13.7 billion loss for FY 2022, much of…
Tag: deals
AbbVie Pays Capsida $70M to Expand Gene Therapy Alliance to Eye Diseases
AbbVie turned to Capsida Biotherapeutics two years ago for help delivering gene therapies into the brain. That partnership is ongoing, but the pharmaceutical giant now wants to leverage its partner’s technology for delivery of…
Continue Reading
Morning Headlines 2/23/23
February 22, 2023 Headlines No Comments New Releases: SDOH Toolkit and Learning Forum Sessions for the Health IT Community
ONC publishes the “Social Determinants of Health Information Exchange Toolkit” to serve as a…
Moderna Signs On a New Partner in Quest for In Vivo mRNA Gene Editing
Moderna’s ambitions in messenger RNA technology include therapies that do their editing work inside the patient. To that end, the biotech company is starting an R&D collaboration with a division of ElevateBio that brings…
Continue Reading
Blood Clotting Biotech Hemab Hauls In $135M to Drug Rare Bleeding Disorders
Clotting disorders can be treated by infusing patients with clotting proteins they lack, or with drugs that replace the function of these proteins. Gene therapies may soon become another option. Hemophilia A and B…
Continue Reading
GSK’s Covid-19 Valentine to Vir Biotech: ‘You Can Go Your Own Way’
Vir Biotechnology’s Covid-19 research may yield more drugs and perhaps a vaccine, but no longer with the financial support of GSK. The collaboration agreement the two companies struck up in the early days of the pandemic has been amended, leaving Vir to either find another partner or continue its coronavirus research on its own.
The alliance did successfully develop the Covid-19 drug sotrovimab. GSK and Vir will continue to share responsibilities for that drug, which is available under the brand name Xevudy in more than 40 countries. The U.S. is no longer one of them. Last April, the FDA withdrew emergency authorization…
Kami Vision: Detecting and Reporting Elderly Falls
Kami Vision provides technology called KamiCare that helps caregivers in an eldercare community or a person’s home detect and respond quickly to a fall. AI, running right in Kami Vision’s camera, detects falls and reports them to caregivers selected by an app.Watch this short video with CTO Ajay Gulati to see how Kami Vision provides easy setup and flexibility, protects privacy, deals with false alerts, and supports aging in place. Plus, check out their consumer version of KamiCare on Amazon.Learn more about KamiCare: https://kamivision.com/kamicare/Find more great health IT content: https://www.healthcareittoday.com/…
Continue Reading